Genetically Encoded Azide Containing Amino Acid in Mammalian Cells Enables Site-Specific Antibody–Drug Conjugates Using Click Cycloaddition Chemistry
2015 · Bioconjugate Chemistry · 137 citations
https://doi.org/10.1021/acs.bioconjchem.5b00359
J
Jeffrey Johnson
Mayo Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
64
Papers
907
Citations
14
h-index
19
i10-index
Jeffrey Johnson is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Breast Cancer Treatment Studies & CAR-T cell therapy research & Appendicitis Diagnosis and Management. The author has an h-index of 14, co-authored 55 publications.
ORCID: 0000-0003-2912-443XPapers by this author
worksPhase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma (CALGB 500104)
2012 · Journal of Translational Medicine · 79 citations
https://doi.org/10.1186/1479-5876-10-246
Palindromic amplification of the ERBB2 oncogene in primary HER2-positive breast tumors
2017 · Scientific Reports · 41 citations
https://doi.org/10.1038/srep41921
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat